uacc 3199 (ATCC)
Structured Review

Uacc 3199, supplied by ATCC, used in various techniques. Bioz Stars score: 93/100, based on 31 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/product/uacc+3199/pmc12963662-114-10-11?v=ATCC
Average 93 stars, based on 31 article reviews
Images
1) Product Images from "Interplay of Interleukin-1 β and Curcumin on VEGF Expression in Breast Cancer Cells"
Article Title: Interplay of Interleukin-1 β and Curcumin on VEGF Expression in Breast Cancer Cells
Journal: Oncology Research
doi: 10.32604/or.2025.072793
Figure Legend Snippet: ( A ). Cell viability of cells treated with curcumin for 24 h. Viability was determined by the resazurin assay. Data were averaged from three independent experiments with six replicas each, and the standard deviation is shown. ( B) . VEGF concentrations in cell culture supernatant upon 24 h exposure to IL-1β, curcumin, and combinations of both were determined by ELISA for ( B ) MCF-7, ( C ) SK-BR-3, ( D ) MDA-MB-231, and ( E ) UACC-3199. Data are averaged from three independent experiments with two replicas each, and median and quartiles are shown. ( F) . Effects of inhibition of MAP-kinases on curcumin-induced VEGF secretion in MCF-7. SB: SB203580 (p38-MAPK-inhibitor); UO: UO126 (ERK-inhibitor). Data are expressed relative to solvent-treated cells. Data averaged from three independent experiments with three replicas each, and the standard error is shown. * p < 0.05, n.s.: not significant (ANOVA).
Techniques Used: Resazurin Assay, Standard Deviation, Cell Culture, Enzyme-linked Immunosorbent Assay, Inhibition, Solvent
